BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35822421)

  • 21. Outcomes and Trends of Treatments in High-Risk Differentiated Thyroid Cancer.
    Abiri A; Goshtasbi K; Torabi SJ; Kuan EC; Armstrong WB; Tjoa T; Haidar YM
    Otolaryngol Head Neck Surg; 2023 Apr; 168(4):745-753. PubMed ID: 35471863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation Therapy.
    D'Rummo KA; TenNapel MJ; Shen X
    Am J Clin Oncol; 2019 Sep; 42(9):705-710. PubMed ID: 31368905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy.
    Patel SA; Goyal S; Liu Y; Moghanaki D; Patel PR; Hanasoge S; Dhere VR; Shelton JW; Godette KD; Jani AB; Hershatter B; Fischer-Valuck BW
    JAMA Netw Open; 2020 Dec; 3(12):e2025143. PubMed ID: 33301015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes.
    Xu S; Huang H; Qian J; Liu Y; Huang Y; Wang X; Liu S; Xu Z; Liu J
    JAMA Netw Open; 2021 Jul; 4(7):e2118526. PubMed ID: 34313737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TIMING OF RADIOACTIVE IODINE THERAPY DOES NOT IMPACT OVERALL SURVIVAL IN HIGH-RISK PAPILLARY THYROID CARCINOMA.
    Suman P; Wang CH; Abadin SS; Block R; Raghavan V; Moo-Young TA; Prinz RA; Winchester DJ
    Endocr Pract; 2016 Jul; 22(7):822-31. PubMed ID: 27018620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
    Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffuse Sclerosing Papillary Thyroid Carcinoma: Clinicopathological Characteristics and Prognostic Implications Compared with Classic and Tall Cell Papillary Thyroid Cancer.
    Scholfield DW; Fitzgerald CW; Alzumaili B; Eagan A; Xu B; Martinez G; Tuttle RM; Shaha AR; Shah JP; Wong RJ; Patel SG; Ghossein RA; Ganly I
    Ann Surg Oncol; 2023 Aug; 30(8):4761-4770. PubMed ID: 37154968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of radiation therapy facility volume on survival in patients with cancer.
    Tchelebi LT; Shen B; Wang M; Gusani NJ; Walter V; Abrams R; Verma V; Zaorsky NG
    Cancer; 2021 Nov; 127(21):4081-4090. PubMed ID: 34398470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive Value of a Prognostic Model Based on Lymphocyte-to-Monocyte Ratio Before Radioiodine Therapy for Recurrence of Papillary Thyroid Carcinoma.
    Zhou C; Duan D; Liu S
    Technol Cancer Res Treat; 2021; 20():15330338211027910. PubMed ID: 34191658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Influence of Facility Volume and Type on Skull Base Chordoma Treatment and Outcomes.
    Du AT; Pang JC; Victor R; Tang Meller LL; Torabi SJ; Goshtasbi K; Kim MG; Hsu FPK; Kuan EC
    World Neurosurg; 2022 Oct; 166():e561-e567. PubMed ID: 35868508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes of lobectomy for papillary thyroid carcinoma with high-risk features.
    Xu S; Huang H; Wang X; Liu S; Xu Z; Liu J
    Br J Surg; 2021 Apr; 108(4):395-402. PubMed ID: 33793787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer.
    Wang EH; Rutter CE; Corso CD; Decker RH; Wilson LD; Kim AW; Yu JB; Park HS
    J Thorac Oncol; 2015 Jun; 10(6):937-43. PubMed ID: 25738221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model.
    Guo P; Wang X; Xia L; Shawureding N; Hu Z
    Cancer Med; 2023 Apr; 12(7):7868-7876. PubMed ID: 36560883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total Thyroidectomy vs Thyroid Lobectomy for Localized Papillary Thyroid Cancer in Children: A Propensity-Matched Survival Analysis.
    Memeh K; Ruhle B; Alsafran S; Vaghaiwalla T; Kaplan E; Angelos P; Keutgen XM
    J Am Coll Surg; 2021 Jul; 233(1):39-49. PubMed ID: 33887483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphovascular invasion is associated with survival for papillary thyroid cancer.
    Pontius LN; Youngwirth LM; Thomas SM; Scheri RP; Roman SA; Sosa JA
    Endocr Relat Cancer; 2016 Jul; 23(7):555-62. PubMed ID: 27317633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features.
    Suman P; Razdan SN; Wang CE; Tulchinsky M; Ahmed L; Prinz RA; Winchester DJ
    J Am Coll Surg; 2020 Jan; 230(1):136-144. PubMed ID: 31672668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
    Lazarides AL; Kerr DL; Nussbaum DP; Kreulen RT; Somarelli JA; Blazer DG; Brigman BE; Eward WC
    Clin Orthop Relat Res; 2019 Apr; 477(4):718-727. PubMed ID: 30485258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk factors for recurrence and survival analysis in locally advanced T4a papillary thyroid carcinoma after R0 resection].
    Chen JM; Fang JG; Zhong YS; Lin LZ; Hou HZ; Ma L; Feng SZ; He Q; Shi M; Lian R; Wang XX; Shen X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Sep; 57(9):1044-1051. PubMed ID: 36177557
    [No Abstract]   [Full Text] [Related]  

  • 40. Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit?
    Teitelbaum JI; Issa K; Barak IR; Ackall FY; Jung SH; Jang DW; Abi Hachem R
    Otolaryngol Head Neck Surg; 2020 Nov; 163(5):986-991. PubMed ID: 32600116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.